ERBB2 and cancer: In HR-positive HER2-low diseases, the most frequently mutated cancer-associated genes (CAGs)23 were PIK3CA (45%), TP53 (24%), GATA3 (16%) and MAP3K1 (13%) (Supplementary Fig. S10d).